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Original ArticleProne Versus Sitting Position in Neurosurgery—Differences in Patients’ Hemodynamic
ManagementTeemu Luostarinen1, Ann-Christine Lindroos1, Tomohisa Niiya3, Marja Silvasti-Lundell1, Alexey Schramko1,
Juha Hernesniemi2, Tarja Randell1, Tomi Niemi1-OBJECTIVE: Neurosurgery in general anesthesia ex-
poses patients to hemodynamic alterations in both the
prone and the sitting position. We aimed to evaluate the
hemodynamic profile during stroke volumeedirected fluid
administration in patients undergoing neurosurgery either
in the sitting or the prone position.
-METHODS: In 2 separate prospective trials, 30 patients
in prone and 28 patients in sitting position were randomly
assigned to receive either Ringer acetate (RAC) or
hydroxyethyl starch (HES; 130 kDa/0.4) for optimization of
stroke volume. After combining data from these 2 trials,
2-way analysis of variance was performed to compare
patients’ hemodynamic profile between the 2 positions and
to evaluate differences between RAC and HES
consumption.
-RESULTS: To achieve comparable hemodynamics during
surgery, a higher mean cumulative dose of RAC than HES
was needed (679 mL  390 vs. 455 mL  253; P < 0.05).
When fluid consumption was adjusted with weight, sta-
tistical difference was lost. Fluid administration did not
differ between the prone and sitting position. Mean arterial
pressure was lower and cardiac index and stroke volume
index were higher over time in patients in the sitting
position.
-CONCLUSIONS: The sitting position does not require
excess fluid treatment compared with the prone position.
HES is slightly more effective than RAC in achieving









MAP: Mean arterial pressure
RAC: Ringer’s acetate
SV: Stroke volume
WORLD NEUROSURGERY 97: 261-266, JANUARY 2017explained by patient weight. With goal-directed fluid
administration and moderate use of vasoactive drugs, it is
possible to achieve stable hemodynamics in both positions.INTRODUCTIONeurosurgery performed under general anesthesia exposes
patients to hemodynamic alterations (i.e., hypotensionNand changes in cardiac function) in both the prone and
the sitting position.1-4 Regarding intraoperative ﬂuid administra-
tion, it was previously thought that colloids are superior to crys-
talloids in increasing intravascular volume in hypovolemic
patients, but more recent ﬁndings showed that the difference
might be notably smaller than was earlier believed.5,6 Similarly, a
slightly better capability to improve cardiac stroke volume (SV) has
been reported with colloids.5 However, more recent controversies
regarding the safety of colloids safety have diminished their use.7,8
Some neurosurgical procedures can be performed in either the
sitting or the prone position, but comparisons of these 2 positions
are scarce in the literature.9 The aim of the present study was to
compare the intraoperative requirement of 2 study ﬂuids to
achieve stable hemodynamics guided by SV measurement in
neurosurgery performed in the prone versus the sitting position.
MATERIALS AND METHODS
This study consists of 2 separate patient enrollments. In the ﬁrst
phase, adult patients scheduled for elective primary neurosurgery
in the prone position in the Department of Neurosurgery of Hel-
sinki University Central Hospital were included. The second phaseFrom the 1Division of Anesthesiology, Department of Anesthesiology, Intensive Care and Pain
Medicine, and 2Department of Neurosurgery, University of Helsinki and Helsinki University
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position at the same institute. The Ethics Committee for Surgery
of the Hospital District of Helsinki and Uusimaa approved both
trials (Ethics Committee Numbers 13/13/03/04/09 HUS and 396/E9/
2007). Additionally, the National Agency of Medicines in Finland
accepted the study protocols (EudraCT reference number 2009-
009893-28 and EudraCT reference number 2007-007106-30). All
patients provided written informed consent to participate in the
study.
This study uses data acquired from 2 previously executed trials: a
group of patients was operated on in the prone position with
SV-directed administration of study ﬂuids and a different group of
patients was operated on in the sitting position. Results of the dif-
ferences between the study ﬂuids in achieving stable hemodynamics
within 1 surgery position and the effect these 2 ﬂuids have on patient
blood coagulation measured by thromboelastometry analysis
(ROTEM, Pentafarm AG, Basle, Switzerland) have been reported
earlier in 2 separate publications.10,11 Exclusion criteria included age
<18 years old, body mass index >36 kg/m2 in the prone position or
>40 kg/m2 in the sitting position, congestive heart failure, an
electrocardiogram showing other than sinus rhythm, renal failure
(plasma creatinine >120 mmol/L), hepatic failure, anemia (hemo-
globin<100 g/L), and thrombocytopenia (platelet count<100 109/
L). Additionally, expected use of mannitol in the sitting position
resulted in exclusion.
Before anesthesia induction, a basal Ringer acetate (RAC)
infusion was started at the rate of 3 mL/kg/hour (an additional 40
mmol/L of sodium chloride was added to RAC basal infusion of
patients in the sitting position). After induction, anesthesia was
maintained with sevoﬂurane in a mixture of nitrous oxygen and air
and additional fentanyl boluses or a continuous infusion of pro-
pofol (4e10 mg/kg/hour) and remifentanil (0.125e0.25 mg/kg/
min) in patients operated on in the prone position and with a
continuous infusion of propofol (4e12 mg/kg/hour) and remi-
fentanil (0.05e0.45 mg/kg/min) in patients operated on in the
sitting position with the permission to use sevoﬂurane to treat
severe hypertension. After tracheal intubation, volume-controlled
mechanical ventilation without positive end-expiratory pressure
was started (tidal volume 8e10 ml/kg body weight and rate of 10e
15/min) targeting to a normoventilation (arterial carbon dioxide
partial pressure, 4.5e5.0 kPa).
Standard anesthesia monitoring was applied, including nonin-
vasive blood pressure measurement before intubation, electrocar-
diogram, arterial saturation of oxygen, nasopharyngeal
temperature, side stream spirometry (Side Stream; Datex-Ohmeda
Inc., GE Healthcare, Madison, Wisconsin, USA), and end-tidal
concentration of carbon dioxide. Additionally, a 20-gauge arterial
catheter (Becton Dickinson and Company, Temse, Belgium) was
inserted into the radial artery for invasive monitoring of arterial
pressures and to obtain blood samples. To continuously monitor
cardiac output, cardiac index (CI), SV, SV index, and SV variation,
the Vigileo monitor (Edwards Lifesciences Corporation, Irvine,
California, USA) with software version 3.02 was applied by con-
necting it to an arterial line with a pressure transducer set (FloTrac;
Edwards Lifesciences) zeroed at the heart level. For patients oper-
ated on in the sitting position, an additional set was applied and
zeroed at the level of the foramen of Monro for measurement of
systolic, diastolic, and mean arterial pressure (MAP).262 www.SCIENCEDIRECT.com WORLD NEUBoth study sequences (prone and sitting position) had the same
protocol for the study of ﬂuid administration. Patients were
randomly assigned (using closed envelopes drawn in sequential
order by the primary investigators A-C.L. and T.N.) to receive 1 of
the following study solutions:
1. 6% HES solution (Voluven; Fresenius Kabi AG, Bad Homburg,
Germany), 60 mg/mL, average molecular weight 130 kDa,
molar substitution ratio 0.4, pH 4.0e5.5, contents Naþ 154
mmol/L and Cl 154 mmol/L (HES group, 15 patients in prone
position and 15 patients in sitting position).
2. RAC solution (Ringer-Acetat; Fresenius Kabi AG), pH 6.0,
contents Naþ 130 mmol/L, Cl 112 mmol/L, Kþ 4 mmol/L,
Caþþ 2 mmol/L, Mgþþ 1 mmol/L, CH3COO 30 mmol/L (RAC
group, 15 patients in prone position and 13 patients in sitting
position).
After anesthesia induction, all patients received an initial 200-
mL bolus of the study ﬂuid over 2e4 minutes while lying su-
pine, and hemodynamic measurements were performed before
and 3 minutes after administration of the study ﬂuid. A new bolus
of 100 mL over 2e4 minutes was given immediately after the
hemodynamic measurements, until SV did not increase >10%.
The hemodynamic measurements were performed 3 minutes after
each bolus.
Thereafter, patients were positioned for surgery. Patients in the
sitting position were dressed in an antigravity suit before posi-
tioning. Hemodynamic parameters were registered at 5-minute
intervals during surgery. If SV decreased >10% from the value
obtained in the supine position, further study ﬂuid boluses of 100
mL were administered. If the SV did not increase with 3 consec-
utive boluses, the volume expansion was stopped, and the patient
was considered a nonresponder. Hemodynamic parameters were
also registered at the end of surgery and after patient positioning
back to supine position.
The target for MAP was 60 mm Hg at the brain level. Boluses
of phenylephrine (0.05e0.1 mg) or ephedrine (5e10 mg) were
given if MAP was <60 mm Hg despite the study ﬂuid adminis-
tration. A phenylephrine or norepinephrine infusion was started
whenever MAP remained <60 mm Hg for >5 minutes.
Background infusion of RAC (with 0.9% sodium chloride sup-
plement if required) continued at the rate of 1 mL/kg/hour until
the ﬁrst postoperative morning. Urine output and ﬂuid balance
were registered at predetermined intervals.
Patient Positioning
In the prone position, bilateral chest supports were used, and the
patient’s head was placed on a headrest (ProneView Protective
Helmet System; Dupaco, Inc., Oceanside, California, USA) or
ﬁxed with the Sugita pin head holder (Sugita Head Frames; Miz-
uho America, Inc., Union City, California, USA). In the sitting
position, the patient’s upper body was elevated 50e100, and the
head was attached to a head holder (Mayﬁeld; Integra Life-
Sciences, Plainsboro, New Jersey, USA) and tilted 20e30 forward
with the patient sitting with knees slightly ﬂexed on a pillow. For
the detection of possible venous air embolism, the probe of a
precordial Doppler device (Versatone D8 Perioperative Doppler;ROSURGERY, http://dx.doi.org/10.1016/j.wneu.2016.10.005
Table 2. Patient Characteristics According to Surgery Position
Characteristic Prone Sitting P Value
Male/Female 13/17 8/20 NS
Age (years) 54  18 42  15 <0.01
Weight (kg) 79  15 76  14 NS
Height (cm) 170  8 167  9 NS
BSA (m2) 1.93  0.22 1.88  0.20 NS
ASA I/II/III/IV 6/13/10/1 0/0/26/2 <0.001
Ephedrine total dose (mg) 9.2  4.9 4.4  1.3 NS
Phenylephrine total dose (mg) 1.4  1.7 1.4  2.3 NS
Data are presented as mean  SD.
NS, not significant; BSA, body surface area; ASA, American Society of Anesthesiologists.
Table 3. Study Fluid Consumption in 2 Different Surgery
Positions and the Positions Combined
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the right ﬁfth intercostal space lateral to the sternum.
Statistics
We performed this analysis post hoc by combining the data of the
study ﬂuid usage, patient hemodynamics, and basic patient
demographics from the 2 previously executed trials. Two-way
variance of analysis was used to test differences between the
study groups (prone vs. sitting position; HES vs. RAC). When
needed, a t test was used to determine differences between 2
groups. Results are shown as mean  SD. P < 0.05 was consid-
ered statistically signiﬁcant. Hemodynamic data are shown
graphically as means at time points from 0 to 230 at 5-minute
intervals. If needed, the difference between curves could have
been tested using a sign test. In all cases, the P value would be
P  0.000001.
RESULTS
After assessment of 72 patients for eligibility between August 2009
and March 2011, data from 58 patients (30 patients in prone
position and 28 patients in sitting position) were analyzed.
Exclusion ﬂowcharts have been reported in conjunction with the
original reports of both individual studies.10,11
Six patients receiving RAC (2 in sitting position and 4 in prone
position) and 1 patient receiving HES in prone position were
considered nonresponders. The combined data show, when
divided into 2 groups according to the study ﬂuid (RAC vs. HES),
that patients in the RAC group had higher weight, height, and
higher body surface area. However, body mass index was equal in
both groups (Table 1). Cumulative mean dose of basal RAC was
similar between the study groups. When divided according to
the surgery position, the groups were comparable with the
exception that patients in the sitting position were younger
(P < 0.01) and had higher American Society of Anesthesiologists
classiﬁcation (P < 0.001) (Table 2).
The mean cumulative dose of RAC (prone and sitting position
combined) to optimize the ﬂuid ﬁlling at 30 minutes and at end of
surgery was higher than the dose of HES (452 mL  155 vs. 341 mL
 109 and 679 mL  390 vs. 455 mL  253, respectively) (Table 3).Table 1. Patient Characteristics According to Study Fluid
Characteristic HES RAC P Value
Male/female 6/23 15/14 <0.05
Age (years) 48  16 48  19 NS
Weight (kg) 73.3  12.9 82.0  15.4 <0.05
Height (cm) 165.8  8.8 171.6  9.3 <0.05
BSA (m2) 1.83  0.18 1.97  0.23 <0.05
ASA I/II/III/IV 2/8/18/1 4/5/18/2 NS
Basal RAC (mL) 783  218 819  309 NS
Data are presented as mean  SD.
HES, hydroxyethyl starch 130 kDa/0.4; RAC, Ringer acetate; NS, not significant; BSA, body
surface area; ASA, American Society of Anesthesiologists.
WORLD NEUROSURGERY 97: 261-266, JANUARY 2017When RAC and HES doses were adjusted with patient’s weight,
the mean doses at 30 minutes and at the end of surgery for
RAC still remained higher than doses of HES (5.5 mL/kg  1.6
vs. 4.8 mL/kg  1.7 and 8.2 mL/kg  4.2 vs. 6.4 mL/kg  3.6,
respectively), but statistical signiﬁcance was lost. RAC and HES
doses before positioning were similar in both positions.
Regarding patient positioning during surgery, the ﬂuid
consumption of study ﬂuids did not differ between the 2 groups
(Table 3). Patients in the sitting position had lower MAP over
time and higher CI and SV index than patients in the prone
position (Figure 1).
DISCUSSION
The present study shows that with goal-directed ﬂuid adminis-
tration and moderate use of vasoactive drugs, it is possible to





HES total mL 455  253
RAC total mL 679  390 <0.05*
Study fluids combined 586  376 550  319 567  345
HES start bolus mL 255  51
RAC start bolus mL 266  55 NS
Study fluids combined 268  48 253  57 260  53
HES at 30 minutes (mL) 341  109
RAC at 30 minutes (mL) 452  155 <0.001*
Study fluids combined 396  137 397  152 397  144
Data are presented as mean  SD.
HES, hydroxyethyl starch 130 kDa/0.4; RAC, Ringer acetate; NS, not significant.
*Between HES and RAC when positions combined.
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Figure 1. Mean arterial pressure (MAP), cardiac index (CI), and stroke volume index (SVI) over time (minutes) during
surgery in sitting and prone positions.
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excess intravenous ﬂuid administration compared with surgery in
the prone position. Moreover, the beneﬁt of using HES to opti-
mize patient hemodynamics instead of RAC is only marginal.
Neurosurgery in the sitting position was more popular in the
1970s and 1980s than it is today. Even today, there is a great
variation in its use among the countries where the sitting position
is used.12 The sitting position is still often considered preferable
when operating on lesions in the posterior cranial fossa.9,13
Advantages of the sitting position are decreased intracranial
pressure and a clearer operating ﬁeld secondary to gravity forced
downward drainage of blood and cerebrospinal ﬂuid. Neurosur-
gery in the sitting position also decreases the incidence of cranial
nerve damage.13 The sitting position is known to cause
hypotension and decrease in cardiac function, presenting a
challenge to the neuroanesthesiologist in guaranteeing sufﬁcient
cerebral blood pressure and oxygen delivery. Another concern
related to the sitting position is venous air embolism, which has
an incidence of 1.6%e50%, with the incidence being lower in
the semisitting position.1,3,10,14-17
Historically, it was believed that the capability of colloids to
increase intravascular volume in hypovolemic patients would be 2-
to 3-fold compared with crystalloids, but more recent ﬁndings
indicate that 1:1 to 1:1.5e1.8 is the more accurate ratio.5,6,18 A
similar ratio was found in patients undergoing elective neuro-
surgery.10,11 Our results showed a ratio of 1:1.5 between HES and
RAC in achieving comparable hemodynamics, which is in line
with the earlier ﬁndings. Even this might be an overestimation,
because after adjustment with patients’ weight, the difference
between HES and RAC was reduced to 1.3-fold and was no longer
statistically signiﬁcant.
In the present study, we demonstrated that the previously
reported decrease in cardiac function when the prone position is
applied can be prevented with SV-directed ﬂuid administration
and moderate use of vasoactive drugs.19-22 Moreover, with similar
ﬂuid and vasoactive drug administration, patients in the sitting
position maintained good cardiac function after positioning, and
decrease in cardiac function did not occur.1 Although MAP
remained adequate throughout the surgery, it was lower in the
sitting position, conﬁrming a tendency of hypotension in this
position. Patients in the sitting position in our study wore
antigravity suits, which in part prevent pooling of the blood inWORLD NEUROSURGERY 97: 261-266, JANUARY 2017the lower extremities and thus help stabilize patient
hemodynamics. Patients in the sitting position had a higher CI
than patients in the prone position. This possibly reﬂects
patients operated on in the sitting position being healthier and
younger. Anesthesia was maintained with propofol in the sitting
position, whereas mainly volatile anesthetics were used in the
prone position. This adds to the complexity of CI interpretation.23
There are various methods of measuring cerebral perfusion
pressure in neurosurgical patients; we measured the MAP at the
level of the foramen of Monro, giving us a more accurate estimate
of cerebral perfusion pressure. If MAP would have been measured
at the level of the heart, the values would be 15e25 mm Hg higher
and reﬂect the systemic blood pressure more.24,25
Discussion about safety of artiﬁcial colloids is ongoing.
Increased risk of mortality and kidney failure in critically ill pa-
tients associated with the use of HES and related consensus
statements have decreased use of artiﬁcial colloids dramati-
cally.7,8,26 Recent years have seen a plethora of reports trying to
determine whether this risk is real in other patient populations as
well (i.e., general surgery patients). The possible negative effect
colloids have on coagulation is important to bear in mind when
treating neurosurgical patients, as normal coagulation capacity in
this patient population is essential.27 Although the initial ﬁlling
doses of study ﬂuids were not enough to stabilize
hemodynamics before positioning, the total doses of
intraoperative ﬂuids in our study were low, and only a minor
difference in doses was seen between HES and RAC. In that
light, it would be difﬁcult to recommend HES use in
neurosurgical patients operated on in the sitting position.CONCLUSIONS
Neurosurgery with the patient in the sitting position does not require
excessive ﬂuid administration compared with the prone position to
achieve stable hemodynamics. The possible minor beneﬁt gained
from using HES to diminish ﬂuid load is counteracted by the
possible harm associated with the use of artiﬁcial colloids.ACKNOWLEDGMENTS
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